Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 151

Results For "India"

3241 News Found

Dozee unveils ‘Dozee Pro Ex’ for seamless continuum of monitoring from hospital to home
Digitisation | October 09, 2023

Dozee unveils ‘Dozee Pro Ex’ for seamless continuum of monitoring from hospital to home

Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings


Zydus receives final approval from the USFDA for Sugammadex Single-Dose Vial
Drug Approval | October 09, 2023

Zydus receives final approval from the USFDA for Sugammadex Single-Dose Vial

Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide


Reclassify nicotine replacement therapies as prescription drugs, says Doctor
News | October 07, 2023

Reclassify nicotine replacement therapies as prescription drugs, says Doctor

NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts


Lupin receives tentative approval from USFDA for Tolvaptan Tablets
Drug Approval | October 07, 2023

Lupin receives tentative approval from USFDA for Tolvaptan Tablets

Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)


Ministry of Ayush to launch special campaign 3.0,
News | October 06, 2023

Ministry of Ayush to launch special campaign 3.0,

The Main campaign started from October 2


Ministry of Ayush inaugurates the conference on Homeopathy in Kolkata
News | October 06, 2023

Ministry of Ayush inaugurates the conference on Homeopathy in Kolkata

The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April


Apollo launches Hyderabad's first homecare recovery program
News | October 06, 2023

Apollo launches Hyderabad's first homecare recovery program

This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients


Marksans Pharma gets USFDA approval for Esomeprazole Magnesium delayed-release capsules
Drug Approval | October 05, 2023

Marksans Pharma gets USFDA approval for Esomeprazole Magnesium delayed-release capsules

This product is bioequivalent to the reference listed drug (RLD), Nexium 24 HR Delayed- Release Capsules, 2.0mg (OTC), of AstraZeneca Pharmaceuticals


Lupin launches patient support program ‘Humrahi‘  for diabetes management
Healthcare | October 04, 2023

Lupin launches patient support program ‘Humrahi‘ for diabetes management

India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045


Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma
News | October 03, 2023

Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma

The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete